Rockwell Medical logo
Rockwell Medical RMTI
$ 2.07 1.17%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Rockwell Medical Financial Ratios 2011-2024 | RMTI

Annual Financial Ratios Rockwell Medical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.2 -1.1 -1.2 -2.8 -4.9 -4.8 -11.0 -14.2 -21.6 -20.9 -7.1 -2.4 -8.7

P/S

0.4 0.3 0.6 1.4 2.7 2.4 5.0 5.3 5.6 8.2 6.6 2.6 3.8

EPS

-0.4 -1.3 -3.8 -0.4 -0.6 -0.6 -0.5 -0.4 -0.3 -0.5 -1.5 -2.6 -1.2

EV (Enterprise Value)

57.3 M 42.9 M 71.2 M 81.1 M 179 M 156 M 303 M 295 M 306 M 410 M 369 M 153 M 194 M

EBITDA per Share

-0.22 -1.13 -3.48 -0.419 -0.516 -0.582 -0.5 -0.383 -0.287 -0.4 -1.4 -2.61 -1.16

EV/EBITDA

-13.7 -1.3 -4.9 -4.2 -10.9 -13.6 -19.6 -23.0 -7.7 -2.4 -8.8

PEG

-0.04 -0.01 -0.01 -0.12 -0.59 0.24 0.36 0.41 -0.49 -0.32 -0.16 0.02 0.01

P/B

1.7 1.5 15.2 2.5 8.2 5.6 8.7 5.3 5.0 6.5 578.9 -13.1 10.2

P/CF

-3.8 -1.2 -1.1 - -5.8 -7.2 -12.5 -22.0 -18.3 125.0 -6.7 -4.2 -16.4

ROE %

-39.64 -132.42 -1288.92 -90.40 -167.96 -117.78 -78.76 -37.39 -23.14 -31.04 -8191.46 542.28 -117.54

ROA %

-16.18 -40.05 -67.27 -39.73 -77.01 -61.12 -44.10 -23.81 -16.42 -21.76 -134.16 -317.31 -67.14

ROCE %

-31.33 -118.96 -1196.69 -47.56 -106.74 -79.81 -52.23 -27.68 -18.94 -19.91 -254.20 544.70 -118.84

Current Ratio

1.7 1.4 1.1 5.4 3.0 3.5 5.3 7.7 10.5 9.7 1.8 0.5 1.9

DSO

37.5 30.5 29.7 24.5 25.0 42.3 40.5 43.8 33.3 30.1 31.9 32.5 31.5

DIO

28.5 26.3 22.7 24.0 22.8 22.7 52.0 95.2 61.9 31.3 22.4 22.4 21.1

DPO

20.9 20.7 22.4 25.5 18.8 25.2 28.8 46.0 31.4 42.3 69.3 125.5 45.2

Operating Cycle

65.9 56.8 52.4 48.5 47.8 65.0 92.5 139.0 95.2 61.5 54.3 54.9 52.6

Cash Conversion Cycle

45.0 36.1 30.0 23.0 28.9 39.8 63.7 93.1 63.8 19.1 -15.1 -70.6 7.4

All numbers in USD currency

Quarterly Financial Ratios Rockwell Medical

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.05 0.01 -0.06 - -0.07 -0.18 -0.1 - -0.23 -0.43 -0.84 - -0.89 -0.99 -0.91 - -0.1 -0.1 -0.12 - -120 -0.18 -0.15 - -0.1 -0.24 -0.13 -0.18 -0.1 -0.14 -0.09 -0.1 -0.09 -0.11 -0.1 -0.12 -0.05 -0.05 -0.07 -0.14 -0.1 -0.08 -0.2 -0.21 -0.34 -0.38 -0.72 -0.66 -0.86 -0.58 -0.54 -0.49 -0.28 -0.26 -0.17

EBITDA per Share

0.07 0.03 -0.03 - -0.05 -0.15 -0.07 - -0.2 -0.38 -0.76 - -0.75 -0.87 -0.82 - -0.08 -0.07 -0.12 - - -0.17 -0.15 - -0.09 -0.23 -0.11 -0.18 -0.09 -0.13 -0.1 -0.1 -0.08 -0.1 -0.09 -0.12 -0.04 -0.04 -0.07 -0.1 -0.06 -0.05 -0.17 -0.19 -0.3 -0.36 -0.71 -0.64 -0.82 -0.56 -0.53 -0.48 -0.23 -0.23 -0.14

ROE %

-9.91 -24.33 -60.47 -57.34 -83.31 -100.57 -90.54 98.37 30.03 -12.33 -33.82 -144.09 -165.60 -118.78 -92.81 -65.05 -103.70 -120.85 -151.33 -132.02 -150.24 -129.80 -123.99 -83.40 -110.87 -108.01 -84.69 -78.76 -60.84 -54.09 -42.69 -37.39 -37.11 -32.37 -26.31 -23.14 -23.17 -25.07 -25.62 -31.04 -1420.84 -3632.93 -5620.33 -8191.46 -6655.11 -4257.80 -2146.28 542.28 355.96 148.88 4.50 -117.54 -27.63 -24.87 -15.96

ROA %

-3.41 -9.88 -19.22 -16.57 -24.30 -28.48 -28.19 -35.27 -48.18 -53.36 -58.15 -37.27 -46.72 -43.26 -38.94 -28.59 -46.31 -54.58 -68.94 -60.53 -69.99 -61.72 -61.77 -43.29 -58.66 -57.81 -46.59 -44.10 -34.80 -31.68 -26.08 -23.81 -24.31 -21.57 -18.01 -16.42 -16.36 -17.66 -18.01 -21.76 -38.16 -70.44 -99.83 -134.16 -191.56 -260.23 -297.53 -317.31 -265.02 -175.81 -120.09 -67.14 -15.78 -14.21 -9.12

ROCE %

-5.65 -20.37 -53.61 -50.51 -73.49 -88.39 -79.59 92.61 29.77 -10.10 -30.83 -133.26 -152.84 -109.57 -82.99 -59.55 -98.63 -118.14 -152.78 -133.48 -151.80 -131.05 -125.09 -84.37 -112.39 -109.33 -84.66 -78.76 -60.68 -54.39 -44.53 -38.16 -37.95 -33.11 -26.81 -24.23 -21.81 -22.24 -21.45 -25.56 -1282.48 -3354.08 -5327.92 -7901.96 -6500.36 -4244.34 -2146.76 544.70 358.24 150.34 4.76 -118.85 -28.04 -25.30 -16.43

Current Ratio

2.0 1.8 1.7 1.7 1.7 1.3 1.4 1.4 1.4 1.5 0.9 1.1 1.2 1.4 1.6 1.8 1.8 1.8 1.8 1.9 1.9 1.9 1.9 2.1 2.1 2.1 2.1 2.3 2.3 2.3 2.3 - - - - - - - - - - - - - - - - - - - - - - - -

DSO

31.8 38.7 44.2 - 28.4 28.9 28.5 - 37.7 37.1 36.9 - 32.5 36.0 31.8 - 6.3 6.3 6.4 - 24.9 25.8 32.8 - 38.2 42.7 40.7 - 39.6 43.8 39.9 - - - - - - - - - - - - - - - - - - - - - - - -

DIO

24.3 25.6 27.8 - 23.9 30.5 30.5 - 26.0 28.8 25.9 - 24.3 26.1 24.3 - 23.9 23.8 23.4 - 21.6 23.6 24.1 - 25.1 19.5 34.0 - 51.4 59.3 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

12.3 17.7 21.9 - 20.9 29.8 24.7 - 15.3 19.3 21.5 - 27.3 24.4 22.6 - 25.4 25.2 22.2 - 17.9 19.5 23.6 - 27.9 21.6 25.4 - 28.4 32.8 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

56.1 64.4 72.0 - 52.2 59.4 59.0 - 63.7 66.0 62.8 - 56.9 62.1 56.1 - 30.2 30.1 29.8 - 46.5 49.4 56.9 - 63.3 62.2 74.7 - 91.1 103.1 39.9 - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

43.8 46.6 50.1 - 31.4 29.6 34.2 - 48.4 46.7 41.3 - 29.5 37.7 33.5 - 4.9 4.9 7.6 - 28.6 29.9 33.3 - 35.4 40.5 49.3 - 62.6 70.3 39.9 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency